Literature DB >> 29864528

Deubiquitinating enzymes in cancer stem cells: functions and targeted inhibition for cancer therapy.

Kamini Kaushal1, Ainsley Mike Antao1, Kye-Seong Kim2, Suresh Ramakrishna3.   

Abstract

The ability of cancers to evade conventional treatments, such as chemotherapy and radiation therapy, has been attributed to a subpopulation of cancer stem cells (CSCs). CSCs are regulated by mechanisms similar to those that regulate normal stem cells (NSCs), including processes involving ubiquitination and deubiquitination enzymes (DUBs) that regulate the expression of various factors, such as Notch, Wnt, Sonic Hedgehog (Shh), and Hippo. In this review, we discuss the roles of various DUBs involved in the regulation of core stem cell transcription factors and CSC-related proteins that are implicated in the modulation of cellular processes and carcinogenesis. In addition, we discuss the various DUB inhibitors that have been designed to target processes relevant to cancer and CSC maintenance.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29864528     DOI: 10.1016/j.drudis.2018.05.035

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  17 in total

Review 1.  Role of deubiquitinases in DNA damage response.

Authors:  John Le; Eric Perez; Leah Nemzow; Feng Gong
Journal:  DNA Repair (Amst)       Date:  2019-02-21

2.  Deubiquitinating ALDH1A3 key to maintaining the culprit of aggressive brain cancer.

Authors:  Hiroaki Wakimoto
Journal:  J Clin Invest       Date:  2019-04-08       Impact factor: 14.808

3.  Serine Metabolism Regulates YAP Activity Through USP7 in Colon Cancer.

Authors:  Xiaoya Zhao; Jianfei Fu; Bin Hu; Lin Chen; Jing Wang; Jinyong Fang; Chenyang Ge; Haiping Lin; Kailing Pan; Liang Fu; Lude Wang; Jinlin Du; Wenxia Xu
Journal:  Front Cell Dev Biol       Date:  2021-05-12

4.  ISG15 and ISGylation is required for pancreatic cancer stem cell mitophagy and metabolic plasticity.

Authors:  Sonia Alcalá; Patricia Sancho; Paola Martinelli; Diego Navarro; Coral Pedrero; Laura Martín-Hijano; Sandra Valle; Julie Earl; Macarena Rodríguez-Serrano; Laura Ruiz-Cañas; Katerin Rojas; Alfredo Carrato; Laura García-Bermejo; Miguel Ángel Fernández-Moreno; Patrick C Hermann; Bruno Sainz
Journal:  Nat Commun       Date:  2020-05-29       Impact factor: 14.919

5.  Seneca Valley Virus 3C protease negatively regulates the type I interferon pathway by acting as a viral deubiquitinase.

Authors:  Qiao Xue; Huisheng Liu; Zixiang Zhu; Fan Yang; Qinghong Xue; Xuepeng Cai; Xiangtao Liu; Haixue Zheng
Journal:  Antiviral Res       Date:  2018-11-05       Impact factor: 5.970

6.  Ubiquitin-Specific Protease 3 Deubiquitinates and Stabilizes Oct4 Protein in Human Embryonic Stem Cells.

Authors:  Byung-Ho Rhie; Ainsley Mike Antao; Janardhan Keshav Karapurkar; Min-Seong Kim; Won-Jun Jo; Suresh Ramakrishna; Kye-Seong Kim
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

Review 7.  Emerging Roles of Ubiquitin-Specific Protease 25 in Diseases.

Authors:  Wenjing Zhu; Dandan Zheng; Dandan Wang; Lehe Yang; Chengguang Zhao; Xiaoying Huang
Journal:  Front Cell Dev Biol       Date:  2021-06-23

8.  Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines.

Authors:  Tamara Mirzapoiazova; Alexander Pozhitkov; Arin Nam; Isa Mambetsariev; Michael S Nelson; Yi-Hung Carol Tan; Keqiang Zhang; Dan Raz; Sharad Singhal; Mohd W Nasser; Prakash Kulkarni; Surinder K Batra; Martin Sattler; Ravi Salgia
Journal:  Int J Oncol       Date:  2020-04-01       Impact factor: 5.650

Review 9.  Advances in Deubiquitinating Enzyme Inhibition and Applications in Cancer Therapeutics.

Authors:  Ainsley Mike Antao; Apoorvi Tyagi; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Cancers (Basel)       Date:  2020-06-15       Impact factor: 6.639

10.  E3 Ubiquitin Ligase APC/CCdh1 Negatively Regulates FAH Protein Stability by Promoting Its Polyubiquitination.

Authors:  Kamini Kaushal; Sang Hyeon Woo; Apoorvi Tyagi; Dong Ha Kim; Bharathi Suresh; Kye-Seong Kim; Suresh Ramakrishna
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.